US Patent Issued to NATIONAL CANCER CENTER, PROTANBIO on June 9 for "Chimeric antigen receptor targeting BCMA and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,785, issued on June 9, was assigned to NATIONAL CANCER CENTER (Goyang-si, South Korea) and PROTANBIO INC. (Seoul, South Korea).

"Chimeric antigen receptor targeting BCMA and use thereof" was invented by Sangjin Lee (Paju-si, South Korea), Hyeonseok Eom (Seoul, South Korea), Eunjung Park (Seoul, South Korea), Bumkyu Choi (Paju-si, South Korea), Soyoun Ro (Incheon, South Korea), Seongwon Hong (Goyang-si, South Korea), Chungyong Han (Goyang-si, South Korea), Jeyoel Cho (Seoul, South Korea), Hyejin Sung (Seoul, South Korea) and Siyoung Choi (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "An antibody specifically binding to BCMA (B-cell...